Serologic Response to Inactivated Poliovirus Vaccine: A Randomized Clinical Trial Comparing 2 Vaccination Schedules in Puerto Rico | Zendy

Gustavo H. Dayan | Zendy; Margaret Thorley | Zendy; Yasuhiro Yamamura | Zendy; Nayra Rodríguez | Zendy; Stephen McLaughlin | Zendy; Lourdes M. Torres | Zendy; Antonio Seda | Zendy; Marcia Carbia | Zendy; Lorraine N. Alexander | Zendy; Victor M. Cáceres | Zendy; Mark A. Pallansch | Zendy

Open Access

Serologic Response to Inactivated Poliovirus Vaccine: A Randomized Clinical Trial Comparing 2 Vaccination Schedules in Puerto Rico

Author(s) -

Gustavo H. Dayan,

Margaret Thorley,

Yasuhiro Yamamura,

Nayra Rodríguez,

Stephen McLaughlin,

Lourdes M. Torres,

Antonio Seda,

Marcia Carbia,

Lorraine N. Alexander,

Victor M. Cáceres,

Mark A. Pallansch

Publication year - 2006

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/508427

Subject(s) - poliovirus , inactivated poliovirus vaccine , seroconversion , medicine , vaccination , poliomyelitis , immunogenicity , virology , immunization , immunology , pediatrics , antibody , virus

The World Health Organization (WHO) recommends the discontinuation of oral poliovirus vaccine after eradication of wild poliovirus. Studies assessing inactivated poliovirus vaccine (IPV) immunogenicity in tropical countries, using the WHO Expanded Programme on Immunization (EPI) schedule, have been limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research